Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CSTLthis companyCastle Biosciences, Inc.	$32.57	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
BDSXBiodesix, Inc.	$7.92	-1.46×	-20.83×	0.58×	-4.79×	-1313.6%	81.1%	-31.4%	-39.8%	1430.6%	-38.9%	-46.1%	-29.56×	-2.45×	-3.6×	1.86×	0.0%	4	-5.55	1	D+
BIAFbioAffinity Technologies, Inc.	$2.65	-0.14×	0.28×	0.33×	0.23×	-141990.8%	23.2%	-171.6%	-242.0%	-204.9%	-125.3%	-462.3%	0.16×	0.37×	-238.27×	2.6×	0.0%	3	-16.55	2	C
FRFRNMFreenome, Inc.	$10.84	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
GHGuardant Health, Inc.	$157.35	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
MYGNMyriad Genetics, Inc.	$5.77	-1.55×	1.56×	0.7×	-1.92×	-408.9%	69.9%	-8.2%	-44.4%	-99.4%	-10.8%	-4.5%	0.57×	-0.18×	-6.46×	2.49×	0.0%	4	-0.56	1	C-
Peer median	—	-1.5×	-10.28×	0.64×	-3.35×	-861.2%	67.2%	-37.9%	-43.4%	159.9%	-32.0%	-25.3%	-8.53×	-1.32×	-59.33×	2.54×	0.0%	4	-3.05	2	—